{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"15"},{"groupId":"OG001","value":"42"}],"units":"Participants"}],"description":"Aplastic anemia is a disorder in which the bone marrow greatly decreases or stops production of blood cells.\n\nIn aplastic anemia, the basic structure of the marrow becomes abnormal, and those cells responsible for generating blood cells (hematopoietic cells) are greatly decreased in number or absent. These hematopoietic cells are replaced by large quantities of fat.","groups":[{"description":"Cyclophosphamide 60mg/kg IV over 2 hours Fludarabine 25 mg/m2 IV over 30 minutes DLI Cell Dose 1.0 x 10\\^8 CD3+ T-cells/kg","id":"OG000","title":"DLI Cell Dose of 1.0 x 10^8 CD3+ T-cells/kg"},{"description":"Cyclophosphamide 60mg/kg IV over 2 hours Fludarabine 25 mg/m2 DLI Cell Dose 0.5 x 10\\^8 CD3+ T-cells/kg","id":"OG001","title":"DLI Cell Dose of 0.5 x 10^8 CD3+ T-cells/kg"}],"paramType":"COUNT_OF_PARTICIPANTS","reportingStatus":"POSTED","timeFrame":"Day 100","title":"Number of Patients With Bone Marrow Aplasia","type":"SECONDARY","unitOfMeasure":"Participants"}